Accelrys Discovery Studio 2.5 - a powerful client-server software system that implements a full set of all the necessary tools needed to predict the fundamental properties and processes of organic crystalline materials, inorganic materials, as well as polymeric and soft materials.

Year: 2010
Version: 2.5.0.9164
Developer: Accelrys Software Inc.
Platform: x86
Compatibility with Vista: complete
Language: English
Tabletka: Present

Description: American company Accelrys Software Inc., One of the leading producers of software for chemical research in the field of pharmaceuticals and biotechnology. Formed in 2001 through a merger of five companies: Molecular Simulations Inc. (MSI), Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd. Already in 2004, Accelrys Software Inc. acquired SciTegic, the manufacturer of the Pipeline Pilot software, which serves as the connection of several pieces of software from different vendors, thereby promoting the strengthening of market position of this software.
Strengthening the position Accelrys Software Inc., Will undoubtedly have a huge impact on the world market to develop new drugs and computer applications for the biotechnology sector. Computer technology drastically reduces the time and cost of developing new drugs and is the next generation of software products for the biotechnology industry.

Overview of software for biological research:

Typically, the process of developing new drugs begins with the identification of proteins responsible for the appearance or progression of the disease in the body (target protein). The task of the next stage is to identify or obtain the substance (inhibitor) to block the biological function of disease-causing protein and another charge of a number of requirements, such as compliance with standards acceptable toxicity, the possibility of obtaining a commercial scale, etc. Here, researchers are faced with the need to operate with huge amounts of information about possible molecular structures of the potential inhibitor and its properties.

One key issue is the identification of an inhibitor that has minimal energy of binding to protein. Pharmaceutical and biotechnology companies solve this problem by searching libraries of chemical compounds (high throughput screening) using special machines for the Chemical and Biological Screening, processing hundreds of thousands of substances. The alternative is calculated on large computer clusters. Even the most advanced methods used by market leaders in these calculations are based on empirical models that lead to fatal errors. The amount of error in those calculations is comparable with calculated value, which leads to a considerable increase in the search for inhibitors. This takes the bulk of financial and time resources that stage. This stage of drug development is delayed by an average of three years, at considerable cost to pharmaceutical companies and is an independent business for many companies (Lead Identification and Lead Optimization). But more importantly, in need of new drugs have to "wait" until it appears in drugstores (those who still can "wait").

For users working in the field of biological and pharmaceutical research, Accelrys Software Inc. offers a client-server software system Accelrys Materials Studio-based system CP Workgroup System and control software XC Cluster. Collaboration with IBM allowed Accelrys Software Inc. develop applications that reduce the cycle of drug development due to the accumulation and reuse of data from the relevant applications Accelrys and other software products. As part of Discovery Studio includes support for data integration technologies IBM DiscoveryLink.

System requirements:
-OS: Windows 2003 Server (SP1 and SP2), Windows XP (SP2 and SP3), Windows Vista, Business and Enterprise Editions (SP1), Windows Server 2008.
-CPU: 2 GHz
-RAM: 2 GB
-HDD: 3.4 GB